Delivery Order SPE2DB20D3103-SPE2DB21FP8P4

Award Date 8/11/21
Potential Completion Date 8/12/21
Potential Value $13K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Tivicay 50 mg tablets to the Defense Logistics Agency (DLA). The $3,637.74 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 14, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. Both companies are for-profit...
This federal contract award is for the delivery of TIVICAY 50 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical...
This federal contract award is for the delivery of pharmaceutical products, specifically the drug Tivicay 50 mg tablet, to the Defense Logistics Agency (DLA) with a total ceiling value of $8,539.87. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 26, 2021, with the award being made on October 25, 2021. The contract is a delivery order under a larger Indefinite...
This federal contract award is for $100,572.48 to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Tivicay 50 mg tablets. The contract is a delivery order under the Defense Logistics Agency's (DLA) Troop Support Medical Indefinite Delivery Contract (IDC), which has a ceiling value of $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as the prime contractor. The contract, valued at $32,738.28, is a firm fixed price delivery order for the supply of Tivicay 50 mg tablets. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver...
This contract award is for the supply of the pharmaceutical product TIVICAY 50 MG TABLET 30S to the Defense Logistics Agency (DLA), a defense agency. The fixed-price delivery order, valued at $5,500.86, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies globally. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
This federal contract award, valued at $35,076.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The IDC covers a comprehensive range of pharmaceutical products and medical supplies, including specialty...
This federal contract award is for the delivery of Tivicay 50 mg tablets to the Defense Logistics Agency (DLA). The $5,001.42 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of December 15, 2023 and was awarded on December 14, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal...
This federal contract award, valued at $2,668.64, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order for the supply of TIVICAY 50 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 8, 2025 and is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,745.19, is a delivery order from the Defense Logistics Agency (DLA) Troop Support Medical division, a defense agency that supports military healthcare programs. The contract is for the delivery of Tivicay 50 mg tablets, a prescription medication, with an ultimate completion date of July 19, 2024. The contract is a firm fixed-price...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB21FP8P4
    Delivery Order

This federal contract award is for the delivery of Tivicay 50 mg tablets to the Defense Logistics Agency (DLA) for a total ceiling value of $12,571.56. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a separate IDC with the Department of Justice Federal Bureau of Investigation valued at up to $750,000 for similar medical products and prescription drugs.

Generated 2/27/25, 1:12 PM